Biochemical recurrence surrogacy for clinical outcomes after radiotherapy for adenocarcinoma of the prostate

S Roy, T Romero, JM Michalski, FY Feng… - Journal of Clinical …, 2023 - ascopubs.org
PURPOSE The surrogacy of biochemical recurrence (BCR) for overall survival (OS) in
localized prostate cancer remains controversial. Herein, we evaluate the surrogacy of BCR …
被引用次数：14 相关文章

Biochemical recurrence surrogacy for clinical outcomes after radiotherapy for adenocarcinoma of the prostate

S Roy, JM Michalski - 2023 - digitalcommons.wustl.edu
Biochemical recurrence surrogacy for clinical outcomes after radiotherapy for
adenocarcinoma of the prostate Page 1 Washington University School of Medicine Digital …
[HTML] nih.gov

[HTML][HTML] Biochemical Recurrence Surrogacy for Clinical Outcomes After Radiotherapy for Adenocarcinoma of the Prostate

S Roy, T Romero, JM Michalski, FY Feng… - Journal of Clinical …, 2023 - ncbi.nlm.nih.gov
PURPOSE The surrogacy of biochemical recurrence (BCR) for overall survival (OS) in
localized prostate cancer remains controversial. Herein, we evaluate the surrogacy of BCR …
[PDF] eur.nl

[PDF][PDF] Biochemical Recurrence Surrogacy for Clinical Outcomes After Radiotherapy for Adenocarcinoma of the Prostate

J Clin Oncol, 2023 - pure.eur.nl
Biochemical Recurrence Surrogacy for Clinical Outcomes After Radiotherapy for
Adenocarcinoma of the Prostate Page 1 Original Reports | Genitourinary Cancer …

Biochemical Recurrence Surrogacy for Clinical Outcomes After Radiotherapy for Adenocarcinoma of the Prostate.

S Roy, T Romero, JM Michalski, FY Feng… - Journal of Clinical …, 2023 - repository.icr.ac.uk
PURPOSE: The surrogacy of biochemical recurrence (BCR) for overall survival (OS) in
localized prostate cancer remains controversial. Herein, we evaluate the surrogacy of BCR …

Biochemical Recurrence Surrogacy for Clinical Outcomes after Radiotherapy for Adenocarcinoma of the Prostate

S Roy, T Romero, JM Michalski, FY Feng… - Journal of Clinical …, 2023 - profiles.wustl.edu
PURPOSEThe surrogacy of biochemical recurrence (BCR) for overall survival (OS) in
localized prostate cancer remains controversial. Herein, we evaluate the surrogacy of BCR …

Biochemical Recurrence Surrogacy for Clinical Outcomes After Radiotherapy for Adenocarcinoma of the Prostate.

S Roy, T Romero, JM Michalski, FY Feng… - Journal of Clinical …, 2023 - europepmc.org
Purpose The surrogacy of biochemical recurrence (BCR) for overall survival (OS) in
localized prostate cancer remains controversial. Herein, we evaluate the surrogacy of BCR …

Biochemical Recurrence Surrogacy for Clinical Outcomes After Radiotherapy for Adenocarcinoma of the Prostate

S Roy, T Romero, JM Michalski… - Journal of clinical …, 2023 - pubmed.ncbi.nlm.nih.gov
Purpose The surrogacy of biochemical recurrence (BCR) for overall survival (OS) in
localized prostate cancer remains controversial. Herein, we evaluate the surrogacy of BCR …

Biochemical Recurrence Surrogacy for Clinical Outcomes After Radiotherapy for Adenocarcinoma of the Prostate.

S Roy, T Romero, J Michalski, F Feng… - Journal of Clinical …, 2023 - escholarship.org
PURPOSE: The surrogacy of biochemical recurrence (BCR) for overall survival (OS) in
localized prostate cancer remains controversial. Herein, we evaluate the surrogacy of BCR …
[PDF] core.ac.uk

[PDF][PDF] Biochemical Recurrence Surrogacy for Clinical Outcomes After Radiotherapy for Adenocarcinoma of the Prostate

J Clin Oncol, 2023 - core.ac.uk
Biochemical Recurrence Surrogacy for Clinical Outcomes After Radiotherapy for
Adenocarcinoma of the Prostate Page 1 Original Reports | Genitourinary Cancer …